Malignant Vaginal Neoplasm — Trials

Malignant Vaginal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

127 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 31
Recruiting: 20
Ph III recruiting: 2
Growth YoY: —
Industry share: 19%
Top sponsor: National Cancer Institute (NCI)
Termination share: 29.3%
Trials / 1,000 deaths: 70.8 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (13)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03634267	MRI-Guided Brachytherapy in Treating Participants With HPV-Associated Stage IB2-IVA Cervical or Stage II-IVA Vaginal Cancer	terminated	Phase 1	26	M.D. Anderson Cancer CenterOTHER	1	Sep 15, 2026	clinicaltrials
NCT03277482	Durvalumab, Tremelimumab + Radiotherapy in Gynecologic Cancer	terminated	Phase 1	16	Dana-Farber Cancer InstituteOTHER	1	May 31, 2025	clinicaltrials